SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

26 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 1544.72 millions, about 15.36% up against Rs. 1338.99 millions recorded during the year-ago period.The Total Profit for the quarter ended March 2025 of Rs. 115.92 millions grew from Rs.-320.01 millionsOperating Profit saw a handsome growth to 253.28 millions from 224.87 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1544.72 1338.99 15.36 5426.02 4734.18 14.61 5426.02 4734.18 14.61
Other Income 135.72 64.53 110.32 194.04 86.86 123.39 194.04 86.86 123.39
PBIDT 253.28 224.87 12.63 1018.31 849.51 19.87 1018.31 849.51 19.87
Interest 60.76 60.11 1.08 279.04 296.80 -5.98 279.04 296.80 -5.98
PBDT 192.52 -278.52 -169.12 739.27 109.43 575.56 739.27 109.43 575.56
Depreciation 75.31 72.98 3.19 279.18 276.20 1.08 279.18 276.20 1.08
PBT 117.21 -351.50 -133.35 460.09 -166.77 -375.88 460.09 -166.77 -375.88
TAX 1.29 -31.49 -104.10 30.79 -23.49 -231.08 30.79 -23.49 -231.08
Deferred Tax 1.29 -31.49 -104.10 30.79 -37.05 -183.10 30.79 -37.05 -183.10
PAT 115.92 -320.01 -136.22 429.30 -143.28 -399.62 429.30 -143.28 -399.62
Equity 157.92 137.99 14.44 157.92 137.99 14.44 157.92 137.99 14.44
PBIDTM(%) 16.40 16.79 -2.37 18.77 17.94 4.59 18.77 17.94 4.59

Bajaj Healthcare Share Price

348.95 -1.50 (-0.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×